
5 Things to Know About Clinical Pathways
Learn where clinical care pathways stand today and what the future holds with respect to developing and implementing them.
Standardizing treatment, avoiding waste, helping clinical decisions when faced with multiple care options, improving the quality of care, and controlling costs—this is what clinical pathways aim to achieve. However, pathways are a work in progress and the field is concurrently learning and evolving. Here are 5 things on where clinical pathways stand today:
1. Where Are We Now With Clinical Pathways?
Researchers from the Analysis Group and the National Pharmaceutical Council
2. Using Evidence to Develop Clinical Pathways
Researchers from the Carnegie Mellon University have
3. Barriers to the Adoption of Clinical Pathways
Pathways are still a young enterprise so barriers to their adoption are being more readily recognized than the number of problems being solved,
To read a Twitter conversation with Dr Dubois on the topic, use #AJMCchat.
4. Finding a Place for Precision Medicine in Care Pathways
Can payers surge ahead of the cookie-cutter approach with pathway development and make pathways more personalized? Foundation Medicine believes they can, and should. In an
5. ASCO Unhappy With Current Status of Clinical Pathways
The American Society of Clinical Oncology (ASCO)’s Task Force on Clinical Pathways has asked for greater transparency with pathway development, increased flexibility, and evidence of improved outcomes subsequent to pathway implementation. The task force has expressed concerns with lack of consistency, rigidity, emphasis on cost control, and transparency with the current pathways, and made several
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.